Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMT310 for Acne Rosacea
NCT05108025Phase 2Unknown
- Sponsor
- Dermata Therapeutics
- Start
- Nov 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of DMT310 in rosacea (2 arms), sponsored by Dermata Therapeutics. Status: unknown.
02
Drugs
DMT310
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT05108025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05108025.